Otsuka (OTCMKTS:OTSKY) Releases FY 2025 Earnings Guidance

Otsuka (OTCMKTS:OTSKY) updated its FY 2025 earnings guidance on Friday. The company provided EPS guidance of 3.360-3.360 for the period. The company issued revenue guidance of $15.6 billion-$15.6 billion.

Otsuka Price Performance

Shares of OTSKY stock traded up $0.86 on Friday, reaching $26.48. 37,745 shares of the company were exchanged, compared to its average volume of 44,546. Otsuka has a one year low of $17.74 and a one year high of $32.41. The company has a 50-day moving average of $26.78 and a 200-day moving average of $28.02.

About Otsuka

Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.